Heim539523 • BOM
add
Alkem Laboratories Ltd
Við síðustu lokun
4.723,95 ₹
Dagbil
4.609,50 ₹ - 4.752,90 ₹
Árabil
4.409,90 ₹ - 6.440,00 ₹
Markaðsvirði
553,45 ma. INR
Meðalmagn
3,59 þ.
V/H-hlutf.
25,73
A/V-hlutfall
0,91%
Aðalkauphöll
NSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(INR) | des. 2024info | Breyting á/á |
---|---|---|
Tekjur | 33,74 ma. | 1,52% |
Rekstrarkostnaður | 14,96 ma. | 8,29% |
Nettótekjur | 6,26 ma. | 5,19% |
Hagnaðarhlutfall | 18,55 | 3,63% |
Hagnaður á hvern hlut | 52,34 | -2,59% |
EBITDA | 7,39 ma. | 4,74% |
Virkt skatthlutfall | 12,35% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(INR) | des. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 22,89 ma. | -36,59% |
Heildareignir | — | — |
Heildarskuldir | — | — |
Eigið fé alls | 119,10 ma. | — |
Útistandandi hlutabréf | 119,57 m. | — |
Eiginfjárgengi | 4,91 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 12,59% | — |
Peningaflæði
Breyting á handbæru fé
(INR) | des. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 6,26 ma. | 5,19% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Stofnsett
1973
Höfuðstöðvar
Vefsvæði
Starfsfólk
17.432